Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C88318
http://purl.obolibrary.org/obo/NCIT_C88318
|
|---|---|
| Preferred Name | Canerpaturev |
| Definitions |
A non-engineered, naturally oncolytic, replication-competent spontaneous herpes simplex virus (HSV) type I mutant variant. Upon intratumoral injection, canerpaturev transfects, replicates in, and lyses rapidly dividing cells such as tumor cells. In addition, this agent may increase host immune responses that may kill non-infected tumor cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A non-engineered, naturally oncolytic, replication-competent spontaneous herpes simplex virus (HSV) type I mutant variant. Upon intratumoral injection, canerpaturev transfects, replicates in, and lyses rapidly dividing cells such as tumor cells. In addition, this agent may increase host immune responses that may kill non-infected tumor cells. |
|---|---|
| prefLabel | Canerpaturev
|
| label | Canerpaturev
|
| NCI_META_CUI | CL413628
|
| PDQ_Closed_Trial_Search_ID | 660850
|
| code | C88318
|
| prefixIRI | NCIT:C88318
|
| in_subset |
See more
See less
|
| Display_Name | Canerpaturev
|
| Preferred_Name | Canerpaturev
|
| FDA_UNII_Code | O3F5D10T4M
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Canerpaturev
|
| CAS_Registry | 1662666-66-1
|
| NCI_Drug_Dictionary_ID | 660850
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 660850
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |